CSBR vs GILD · P/E 16, rev $56.9M vs P/E 18, rev $29.44B
Champions Oncology Inc (CSBR) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CSBR and GILD stock pages for the full models.
Not investment advice.